These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 34299149)
1. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy. Peng F; Fan H; Li S; Peng C; Pan X Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149 [TBL] [Abstract][Full Text] [Related]
2. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer. Peng F; Xiong L; Tang H; Peng C; Chen J Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253 [TBL] [Abstract][Full Text] [Related]
3. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer. Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333 [TBL] [Abstract][Full Text] [Related]
5. Regulation of mesenchymal phenotype by MicroRNAs in cancer. Yan J; Gumireddy K; Li A; Huang Q Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of microRNAs in regulating epithelial-mesenchymal transitions in human cancers. Tang J; Li Y; Wang J; Wen Z; Lai M; Zhang H Cancer Lett; 2016 Feb; 371(2):301-13. PubMed ID: 26683775 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition. Zhao X; Lu Y; Nie Y; Fan D Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189 [TBL] [Abstract][Full Text] [Related]
8. Regulating miRNA by natural agents as a new strategy for cancer treatment. Sethi S; Li Y; Sarkar FH Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review). Jin D; Fang Y; Li Z; Chen Z; Xiang J Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189 [TBL] [Abstract][Full Text] [Related]
10. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential. Nie D; Fu J; Chen H; Cheng J; Fu J Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781524 [TBL] [Abstract][Full Text] [Related]
11. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and signaling networks involved in epithelial-mesenchymal transition. Musavi Shenas MH; Eghbal-Fard S; Mehrisofiani V; Abd Yazdani N; Rahbar Farzam O; Marofi F; Yousefi M J Cell Physiol; 2019 May; 234(5):5775-5785. PubMed ID: 30417364 [TBL] [Abstract][Full Text] [Related]
13. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Garg M Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894 [TBL] [Abstract][Full Text] [Related]
14. The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity. Cao MX; Jiang YP; Tang YL; Liang XH Oncotarget; 2017 Feb; 8(7):12472-12483. PubMed ID: 27992370 [TBL] [Abstract][Full Text] [Related]
15. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs regulate the epithelial to mesenchymal transition (EMT) in cancer progression. Hu Y; Tang H Microrna; 2014; 3(2):108-17. PubMed ID: 25323025 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-221: biogenesis, function and signatures in human cancers. Abak A; Amini S; Sakhinia E; Abhari A Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255 [TBL] [Abstract][Full Text] [Related]
19. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Li Y; Kong D; Wang Z; Sarkar FH Pharm Res; 2010 Jun; 27(6):1027-41. PubMed ID: 20306121 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs affect tumor metastasis through regulating epithelial- mesenchymal transition. Yang L; Shen X; Li J; Yang J; Le Y; Gong Z Yi Chuan; 2014 Jul; 36(7):637-45. PubMed ID: 25076027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]